Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Mixed epithelial/mesenchymal metaplastic carcinoma (carcinosarcoma) of the breast in BRCA1 carrier.

Suspitsin EN, Sokolenko AP, Voskresenskiy DA, Ivantsov AO, Shelehova KV, Klimashevskiy VF, Matsko DE, Semiglazov VF, Imyanitov EN.

Breast Cancer. 2011 Apr;18(2):137-40. doi: 10.1007/s12282-009-0105-0. Epub 2009 Apr 7.

PMID:
19350356
2.

Low-grade adenosquamous carcinoma of the breast--A case report with a BRCA1 germline mutation.

Noël JC, Buxant F, Engohan-Aloghe C.

Pathol Res Pract. 2010 Jul 15;206(7):511-3. doi: 10.1016/j.prp.2010.01.008. Epub 2010 Mar 1.

PMID:
20189727
3.

Identical clonality of both components of mammary carcinosarcoma with differential loss of heterozygosity.

Zhuang Z, Lininger RA, Man YG, Albuquerque A, Merino MJ, Tavassoli FA.

Mod Pathol. 1997 Apr;10(4):354-62.

PMID:
9110298
4.

Characterization of a breast cancer cell line derived from a germ-line BRCA1 mutation carrier.

Tomlinson GE, Chen TT, Stastny VA, Virmani AK, Spillman MA, Tonk V, Blum JL, Schneider NR, Wistuba II, Shay JW, Minna JD, Gazdar AF.

Cancer Res. 1998 Aug 1;58(15):3237-42.

5.

Carcinosarcoma of the ovary in a patient with a germline BRCA2 mutation: evidence for monoclonal origin.

Sonoda Y, Saigo PE, Federici MG, Boyd J.

Gynecol Oncol. 2000 Feb;76(2):226-9.

PMID:
10637076
6.

High frequency and allele-specific differences of BRCA1 founder mutations in breast cancer and ovarian cancer patients from Belarus.

Bogdanova NV, Antonenkova NN, Rogov YI, Karstens JH, Hillemanns P, Dörk T.

Clin Genet. 2010 Oct;78(4):364-72. doi: 10.1111/j.1399-0004.2010.01473.x.

PMID:
20569256
7.

Double heterozygosity for mutations in the BRCA1 and BRCA2 genes in a breast cancer patient.

Tsongalis GJ, Linfert DR, Johnson RC, Ackroyd R, Berman MM, Ricci A Jr.

Arch Pathol Lab Med. 1998 Jun;122(6):548-50.

PMID:
9625424
8.
9.

Carcinosarcoma of the breast: molecular-biological study for analysis of histogenesis.

Wada H, Enomoto T, Tsujimoto M, Nomura T, Murata Y, Shroyer KR.

Hum Pathol. 1998 Nov;29(11):1324-8.

PMID:
9824116
10.

Prevalence of BRCA1 and BRCA2 mutations in breast cancer patients from Brazil.

Gomes MC, Costa MM, Borojevic R, Monteiro AN, Vieira R, Koifman S, Koifman RJ, Li S, Royer R, Zhang S, Narod SA.

Breast Cancer Res Treat. 2007 Jul;103(3):349-53. Epub 2006 Oct 25.

PMID:
17063270
11.

Ashkenazi founder BRCA1/BRCA2 mutations in Slovak hereditary breast and/or ovarian cancer families.

Cierniková S, Tomka M, Kovác M, Stevurková V, Zajac V.

Neoplasma. 2006;53(2):97-102.

PMID:
16575464
12.

The contribution of founder mutations in BRCA1 to breast cancer in Belarus.

Uglanitsa N, Oszurek O, Uglanitsa K, Savonievich E, Lubiński J, Cybulski C, Debniak T, Narod SA, Gronwald J.

Clin Genet. 2010 Oct;78(4):377-80. doi: 10.1111/j.1399-0004.2010.01439.x.

PMID:
20507347
13.

Cytogenetic analysis shows that carcinosarcomas of the breast are of monoclonal origin.

Teixeira MR, Qvist H, Bøhler PJ, Pandis N, Heim S.

Genes Chromosomes Cancer. 1998 Jun;22(2):145-51.

PMID:
9598802
14.

Five recurrent BRCA1/2 mutations are responsible for cancer predisposition in the majority of Slovenian breast cancer families.

Krajc M, Teugels E, Zgajnar J, Goelen G, Besic N, Novakovic S, Hocevar M, De Grève J.

BMC Med Genet. 2008 Sep 10;9:83. doi: 10.1186/1471-2350-9-83.

15.

Founder mutations in the BRCA1 gene in Polish families with breast-ovarian cancer.

Górski B, Byrski T, Huzarski T, Jakubowska A, Menkiszak J, Gronwald J, Pluzańska A, Bebenek M, Fischer-Maliszewska L, Grzybowska E, Narod SA, Lubiński J.

Am J Hum Genet. 2000 Jun;66(6):1963-8. Epub 2000 Apr 28.

17.

Founding BRCA1 mutations in hereditary breast and ovarian cancer in southern Sweden.

Johannsson O, Ostermeyer EA, Håkansson S, Friedman LS, Johansson U, Sellberg G, Brøndum-Nielsen K, Sele V, Olsson H, King MC, Borg A.

Am J Hum Genet. 1996 Mar;58(3):441-50.

18.

Genetic testing for a BRCA1 mutation: prophylactic surgery and screening behavior in women 2 years post testing.

Botkin JR, Smith KR, Croyle RT, Baty BJ, Wylie JE, Dutson D, Chan A, Hamann HA, Lerman C, McDonald J, Venne V, Ward JH, Lyon E.

Am J Med Genet A. 2003 Apr 30;118A(3):201-9.

PMID:
12673648
19.

Germline BRCA1-2 mutations in non-Ashkenazi families with double primary breast and ovarian cancer.

Schorge JO, Mahoney NM, Miller DS, Coleman RL, Muller CY, Euhus DM, Tomlinson GE.

Gynecol Oncol. 2001 Nov;83(2):383-7.

PMID:
11606101
20.

Occurrence of both breast and ovarian cancer in a woman is a marker for the BRCA gene mutations: a population-based study from western Sweden.

Einbeigi Z, Bergman A, Meis-Kindblom JM, Flodin A, Bjursell C, Martinsson T, Kindblom LG, Wahlström J, Wallgren A, Nordling M, Karlsson P.

Fam Cancer. 2007;6(1):35-41.

PMID:
16944270

Supplemental Content

Support Center